UBD and non-small cell lung carcinoma: In contrast, “FAT10 (UBD) Cancer Signalling Pathway” (Z score +2.6), “Small Cell Lung Carcinoma” (Z score +1.89), “Non-Small Cell Lung Cancer Signaling” (Z score +2.36), “PI3K Signalling in B lymphocytes” (Z score + 0.8) and “Wnt/Ca+ Pathway” (Z score +0.7) predicted elevated pathway activation for Holstein infected cells.